Arnvind has developed our first commercial GPT-support robot, for use in the Pharma sector.
We are going live with beta testing this week, and expect to ship the model after Easter!
“GPT represents a huge opportunity for companies to increase productivity, and innovate.
ARNVIND GROUP is uniquely positioned to be at the very front of this development, with our MVP-AGILE development team, long standing machine learning practice and OPEN SOURCE commitment.”
BR Peter Arnvind